
Christian Koch
Christian Koch is the CEO of BB Biotech, a prominent investment firm focused on biotechnology companies, primarily based in the United States. Under his leadership, BB Biotech has been actively involved in the biotech acquisition wave, highlighting the sector's innovation and potential for growth amidst the challenges faced by large pharmaceutical firms.
Power2,333
Reach28,849
Country presence
Recent news mentions
Christian Koch is the head of the BB-Biotech mandate at Bellevue Asset Management, commenting on the biotech industry's innovation.
Auch Roche und Novartis sind auf EinkaufstourNeue Zürcher Zeitung·
Switzerland· 2026-06-22
Also mentioned
Christoph Ruckstuhl
